Julie is the current Wellcome Trust Observer on the Stevenage Bioscience Catalyst Board.
At the Wellcome Trust, Julie is a solicitor specialising in IP & commercial transactions. She has specific expertise in the pharmaceutical & life sciences sector. Prior to working at Wellcome she worked for a niche firm whose clients included many biotech companies and universities. Julie also has a PhD in Biochemistry, had a lectureship at a London medical school and worked as a scientist in both research & development directorates at a major UK Pharma company. Since working at Wellcome she has advised the Wellcome Trust Sanger Institute on IP issues and oversaw most of the research contracts awarded by the Innovations division for work on Ebola.